3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
4
Breast Neoplasms
3
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Warts
1
Urinary Bladder Neoplasms
1
Tinea
1
Skin Neoplasms
1
Retinoblastoma
1
Pulmonary Atelectasis
1
Postoperative Complications
1
Pneumonia
1
Papillomavirus Infections
1
Oncology Problem
1
Nevus
1
Multiple Endocrine Neoplasia Type 1
1
Molluscum Contagiosum
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Kidney Failure, Chronic
1
Keratosis, Actinic
1
Intestinal Neoplasms
1
Impetigo
1
Herpes Zoster
1
Heart Diseases
1
Interventions
Gemcitabine
74
Capecitabine
60
Paclitaxel
59
Fluorouracil
58
Oxaliplatin
57
Bevacizumab
51
Docetaxel
50
Leucovorin
48
Nivolumab
40
Cisplatin
40
Irinotecan
39
Carboplatin
37
Cetuximab
34
pembrolizumab
32
Radiosurgery
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Pemetrexed
20
Doxorubicin
20
Albumin-Bound Paclitaxel
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
Mass Screening
×
Clear all
NCT03461341
2020-03-26
ENSURE
St. James's Hospital, Ireland
Completed
3,000 enrolled
NCT04143230
2019-10-29
SST2017
A.O.U. Città della Salute e della Scienza
Phase NA
Completed
660 enrolled